Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 18/20 | 0.70 |
| ▸ | ITGA2B | P08514 | 17/20 | 0.70 |
| ▸ | ITGAV | P06756 | 3/20 | 0.57 |
| ▸ | F2 | P00734 | 1/20 | 0.45 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6677664 | 1.00 | ITGB3 (0.70) | ITGB3ITGA2BITGAVF2KLKB1 | |
| SCHEMBL7435601 | 0.92 | ITGB3 (0.59) | ITGB3ITGA2BITGAV | |
| SCHEMBL7435590 | 0.92 | ITGB3 (0.59) | ITGB3ITGA2BITGAV | |
| SCHEMBL6678683 | 0.89 | ITGB3 (0.57) | ITGB3ITGA2BITGAVKLKB1 | |
| SCHEMBL6677727 | 0.89 | ITGB3 (0.57) | ITGB3ITGA2BITGAVKLKB1 | |
| SCHEMBL7445376 | 0.88 | ITGB3 (0.54) | ITGB3ITGA2BITGAV | |
| SCHEMBL7445367 | 0.88 | ITGB3 (0.54) | ITGB3ITGA2BITGAV | |
| SCHEMBL6677682 | 0.87 | ITGB3 (0.54) | ITGB3ITGA2BITGAV | |
| SCHEMBL6675230 | 0.86 | ITGB3 (0.54) | ITGB3ITGA2BITGAV | |
| SCHEMBL6950146 | 0.86 | ITGB3 (0.54) | ITGB3ITGA2BITGAV |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1995018619-A9 | BICYCLIC FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 2004-10-21 | — | — | WO | disclosed |
| EP-0738150-B1 | BICYCLIC FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 2003-05-02 | — | — | EP | disclosed |
| EP-0674623-B1 | BICYCLIC FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 2003-04-09 | — | — | EP | disclosed |
| US-6403578-B1 | ANTICOAGULANTS, CARDIOVASCULAR DISORDERS | SMITHKLINE BEECHAM CORPORATION | 2002-06-11 | — | — | US | disclosed |
| US-6117866-A | Bicyclic fibrinogen antagonists | SMITHKLINE BEECHAM CORPORATION (US) | 2000-09-12 | — | — | US | disclosed |
| EP-0738150-A4 | BICYCLIC FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 1997-03-19 | — | — | EP | disclosed |
| EP-0738150-A1 | BICYCLIC FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1996-10-23 | — | — | EP | disclosed |
| EP-0674623-A1 | BICYCLIC FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1995-10-04 | — | — | EP | disclosed |
| WO-1995018619-A1 | BICYCLIC FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1995-07-13 | — | — | WO | disclosed |
| WO-1994014776-A2 | BICYCLIC FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1994-07-07 | — | — | WO | disclosed |